US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Allogene Therapeutics Inc.

1.55

-0.0200-1.27%

Post-market: 1.600.0500+3.23%19:07 EDT

Volume:1.09M

Turnover:1.69M

Market Cap:336.76M

PE:-1.17

High:1.59

Open:1.56

Low:1.52

Close:1.57

Loading ...

Overview Company News Filings

Allogene Therapeutics, Inc. (NASDAQ:ALLO) is a favorite amongst institutional investors who own 59%

Simply Wall St.

Allogene Therapeutics to present updated ALLO-316 results at ASCO meeting

William Blair Reaffirms Their Buy Rating on Allogene Therapeutics (ALLO)

William Blair Reaffirms Their Buy Rating on Allogene Therapeutics (ALLO)

FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug

Allogene Gets FDA Fast Track Designations for ALLO-329 in Autoimmune Diseases

MT Newswires Live

BRIEF-Allogene Granted Three U.S. FDA Fast Track Designations (Ftd) For Allo-329

Allogene Therapeutics granted three Fast Track Designations for ALLO-329

Allogene Therapeutics Shares up 2.8% Premarket After Co Granted Three FDA Fast Track Designations for Allo-329

THOMSON REUTERS

Allogene Granted Three U.S. FDA Fast Track Designations (Ftd) for Allo-329, a Next-Generation Dual-Targeted Cd19/Cd70 Allogeneic Car T, for the Treatment of Lupus, Myositis and Scleroderma

THOMSON REUTERS

Allogene Therapeutics Inc: Expects to Initiate Phase 1 Resolution Basket Trial in Mid-2025

THOMSON REUTERS

Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma

Relmada Therapeutics Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

Allogene Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

Allogene Therapeutics Price Target Maintained With a $10.00/Share by RBC Capital

Allogene's Q4 Loss Narrower Than Expected, Revenues Nil

RBC Capital Sticks to Their Buy Rating for Allogene Therapeutics (ALLO)

TD Cowen Keeps Their Buy Rating on Allogene Therapeutics (ALLO)

Allogene Therapeutics Inc Q4 Loss Per Share $0.28

Allogene Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALLO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALLO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALLO\",,,,,undefined,":{"symbol":"ALLO","market":"US","secType":"STK","nameCN":"Allogene Therapeutics Inc.","latestPrice":1.55,"timestamp":1745611200000,"preClose":1.57,"halted":0,"volume":1086380,"hourTrading":{"tag":"盘后","latestPrice":1.6,"preClose":1.55,"latestTime":"19:07 EDT","volume":22693,"amount":35182.56,"timestamp":1745622434494},"delay":0,"floatShares":156266641,"shares":217264738,"eps":-1.32225,"marketStatus":"Market Closed","change":-0.02,"latestTime":"04-25 16:00:00 EDT","open":1.56,"high":1.59,"low":1.52,"amount":1688879.82972,"amplitude":0.044586,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.32225,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1539230400000,"exchange":"NASDAQ","adjPreClose":1.57,"preHourTrading":{"tag":"盘前","latestPrice":1.57,"preClose":1.57,"latestTime":"09:29 EDT","volume":3736,"amount":5865.530087200001,"timestamp":1745587799903},"postHourTrading":{"tag":"盘后","latestPrice":1.6,"preClose":1.55,"latestTime":"19:07 EDT","volume":22693,"amount":35182.56,"timestamp":1745622434494},"volumeRatio":0.5259951145561075,"impliedVol":1.6536,"impliedVolPercentile":0.884},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALLO\",,,,,undefined,":{"symbol":"ALLO","floatShares":156266641,"roa":"-27.01%","roe":"-55.13%","lyrEps":-1.32225,"volumeRatio":0.5259951145561075,"shares":217264738,"dividePrice":0,"high":1.59,"amplitude":0.044586,"preClose":1.57,"low":1.52,"week52Low":1.23,"pbRate":"0.80","psRate":"15307.29","week52High":3.78,"institutionHeld":0,"latestPrice":1.55,"eps":-1.32225,"divideRate":0,"volume":1086380,"delay":0,"ttmEps":-1.32225,"open":1.56,"prevYearClose":2.13,"prevWeekClose":1.45,"prevMonthClose":1.46,"prevQuarterClose":1.46,"fiveDayClose":1.45,"twentyDayClose":1.56,"sixtyDayClose":1.84},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALLO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530181560","title":"Allogene Therapeutics, Inc. (NASDAQ:ALLO) is a favorite amongst institutional investors who own 59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530181560","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530181560?lang=en_us&edition=fundamental","pubTime":"2025-04-25 19:20","pubTimestamp":1745580009,"startTime":"0","endTime":"0","summary":"Significantly high institutional ownership implies Allogene Therapeutics' stock price is sensitive to their trading actions. A total of 10 investors have a majority stake in the company with 51% ownership. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.A look at the shareholders of Allogene Therapeutics, Inc.  can tell us which group is most powerful. And the group that holds the biggest piece of the pie are institutions with 59% ownership. Put another way, the group faces the maximum upside potential .Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. Therefore, a good portion of institutional money invested in the company is usually a huge vote of confidence on its future.Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/allogene-therapeutics-inc-nasdaq-allo-112009356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USJW.SI","LU2095319765.USD","QID","MNQmain","BK4505","ALLO","NDAQ","QLD","IE00BKPKM429.USD",".IXIC","BK4585","BK4588","IE00BGHQF748.EUR","TSYW.SI","USAW.SI","PSQ","BK4112","IE00B3QW5Z07.USD","SQQQ","LU2210150020.SGD","NQmain","IE00B64PRP62.GBP","BK4139","NVIW.SI","LU2210149790.SGD","TQQQ"],"gpt_icon":1},{"id":"2529559633","title":"Allogene Therapeutics to present updated ALLO-316 results at ASCO meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2529559633","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529559633?lang=en_us&edition=fundamental","pubTime":"2025-04-23 22:21","pubTimestamp":1745418065,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics (ALLO) announced that it will present updated data from the completed Phase 1 TRAVERSE trial of ALLO-316 in an oral presentat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allogene-therapeutics-to-present-updated-allo-316-results-at-asco-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allogene-therapeutics-to-present-updated-allo-316-results-at-asco-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ALLO","BK4505"],"gpt_icon":0},{"id":"2529812444","title":"William Blair Reaffirms Their Buy Rating on Allogene Therapeutics (ALLO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529812444","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529812444?lang=en_us&edition=fundamental","pubTime":"2025-04-21 10:35","pubTimestamp":1745202913,"startTime":"0","endTime":"0","summary":"In a report released today, Sami Corwin from William Blair maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report). The company’s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-reaffirms-their-buy-rating-on-allogene-therapeutics-allo-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-reaffirms-their-buy-rating-on-allogene-therapeutics-allo-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALLO"],"gpt_icon":0},{"id":"2526550572","title":"William Blair Reaffirms Their Buy Rating on Allogene Therapeutics (ALLO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2526550572","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526550572?lang=en_us&edition=fundamental","pubTime":"2025-04-10 19:26","pubTimestamp":1744284413,"startTime":"0","endTime":"0","summary":"In a report released today, Sami Corwin from William Blair maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report). The company’s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-reaffirms-their-buy-rating-on-allogene-therapeutics-allo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-reaffirms-their-buy-rating-on-allogene-therapeutics-allo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALLO"],"gpt_icon":0},{"id":"2525318890","title":"FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2525318890","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525318890?lang=en_us&edition=fundamental","pubTime":"2025-04-08 18:46","pubTimestamp":1744109160,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics ALLO announced that the FDA has granted three fast track designations to its investigational CRISPR-based allogeneic CAR-T therapy, ALLO-329.These designations apply to three autoimmune diseases — systemic lupus erythematosus , idiopathic inflammatory myopathy  and diffuse systemic sclerosis .How Does the Fast Track Tag Benefit ALLO’s Drug Development?Fast track designation is designed to facilitate the development and expedite the review of drugs that treat serious conditions, meet an unmet medical need, or offer a potential advantage over existing treatments. Per the FDA, the purpose of granting this designation is to ‘get important new drugs to the patient earlier.’。In the past 60 days, estimates for CytomX Therapeutics’ 2025 EPS have improved from a loss of 31 cents to a profit of 25 cents. During the same timeframe, estimates for loss per share for 2026 have","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-grants-three-fast-track-104600523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFXG0V08.USD","IE00BYQQ9H92.USD","IE00B5TLWC47.USD","ALLO","BK4077","BK4104","IIM","CTMX","BK4585","ETNB","ANIP","BK4505","BK4139","FAST","BK4007","SLE","BK4588","BK4567"],"gpt_icon":0},{"id":"2525423660","title":"Allogene Gets FDA Fast Track Designations for ALLO-329 in Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2525423660","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525423660?lang=en_us&edition=fundamental","pubTime":"2025-04-07 22:20","pubTimestamp":1744035635,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics  said Monday that the US Food and Drug Administration granted three fast track designations for ALLO-329, which the company is developing to treat autoimmune diseases.The designations cover the treatment of adult patients with active refractory moderate-to-severe systemic lupus erythematous, active severe or refractory idiopathic inflammatory myopathy, and active refractory diffuse systemic sclerosis , according to the company.Allogene said FDA's fast track designation is intended to expedite the development and review of therapies that address serious or life-threatening conditions and demonstrate the potential to meet unmet medical needs.The company said it plans to start a phase 1 trial of ALLO-329 in the diseases covered by the three fast track designations in mid-2025, with proof-of-concept from the trial expected by the end of the year.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BYQQ9H92.USD","IE00B5TLWC47.USD","BK4139","IE00BFXG0V08.USD","BK4505","ALLO","FAST","BK4104","BK4585","BK4588","BK4567"],"gpt_icon":0},{"id":"2525804311","title":"BRIEF-Allogene Granted Three U.S. FDA Fast Track Designations (Ftd) For Allo-329","url":"https://stock-news.laohu8.com/highlight/detail?id=2525804311","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525804311?lang=en_us&edition=fundamental","pubTime":"2025-04-07 21:05","pubTimestamp":1744031153,"startTime":"0","endTime":"0","summary":"BRIEF-Allogene Granted Three U.S. FDA Fast Track Designations (Ftd) For Allo-329April 7 (Reuters) - Allogene Therapeutics Inc ALLO.O:ALLOGENE GRANTED THREE U.S. FDA FAST TRACK DESIGNATIONS (FTD) FOR A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL02R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","ALLO"],"gpt_icon":0},{"id":"2525491043","title":"Allogene Therapeutics granted three Fast Track Designations for ALLO-329","url":"https://stock-news.laohu8.com/highlight/detail?id=2525491043","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525491043?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:56","pubTimestamp":1744030588,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics (ALLO) announced that ALLO-329, an investigational dual-targeted CD19/CD70 allogeneic CAR T, has received three Fast Track De...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allogene-therapeutics-granted-three-fast-track-designations-for-allo-329?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allogene-therapeutics-granted-three-fast-track-designations-for-allo-329?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IE00B5TLWC47.USD","BK4230","BK4139","ALLO","BK4505","BK4567","CAR","FAST","IE00BYQQ9H92.USD","BK4104","BK4022","IE00BFXG0V08.USD","BK4588"],"gpt_icon":0},{"id":"2525100680","title":"Allogene Therapeutics Shares up 2.8% Premarket After Co Granted Three FDA Fast Track Designations for Allo-329","url":"https://stock-news.laohu8.com/highlight/detail?id=2525100680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525100680?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:35","pubTimestamp":1744029339,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nL3N3QL17Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","ALLO"],"gpt_icon":0},{"id":"2525102390","title":"Allogene Granted Three U.S. FDA Fast Track Designations (Ftd) for Allo-329, a Next-Generation Dual-Targeted Cd19/Cd70 Allogeneic Car T, for the Treatment of Lupus, Myositis and Scleroderma","url":"https://stock-news.laohu8.com/highlight/detail?id=2525102390","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525102390?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:30","pubTimestamp":1744029012,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL02R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALLO","BK4505","BK4139"],"gpt_icon":0},{"id":"2525010288","title":"Allogene Therapeutics Inc: Expects to Initiate Phase 1 Resolution Basket Trial in Mid-2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2525010288","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525010288?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:30","pubTimestamp":1744029012,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL02R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALLO","BK4505","BK4139"],"gpt_icon":0},{"id":"2525048864","title":"Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma","url":"https://stock-news.laohu8.com/highlight/detail?id=2525048864","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525048864?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:30","pubTimestamp":1744029000,"startTime":"0","endTime":"0","summary":"Designations Follow Recent Investigational New Drug (IND) Application Clearance for the RESOLUTION Basket Study of ALLO-329 in RheumatologyDual CD19/CD70 CAR T Specifically Designed to Enhance Therape","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/07/3056719/0/en/Allogene-Granted-Three-U-S-FDA-Fast-Track-Designations-FTD-for-ALLO-329-a-Next-Generation-Dual-Targeted-CD19-CD70-Allogeneic-CAR-T-for-the-Treatment-of-Lupus-Myositis-and-Scleroder.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALLO","BK4077","FAST","BK4588","IIM","IE00B5TLWC47.USD","BK4567","BK4022","BK4230","BK4505","BK4585","SLE","IE00BFXG0V08.USD","IE00BYQQ9H92.USD","CAR","BK4104"],"gpt_icon":0},{"id":"2522653140","title":"Relmada Therapeutics Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2522653140","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522653140?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:05","pubTimestamp":1743105900,"startTime":"0","endTime":"0","summary":"Expect Topline Phase 2 data for NDV-01 for high-grade non-muscle invasive bladder cancer, to be presented at AUA 2025 in April. Advancing novel neurosteroid, sepranolone, towards Phase 2b study in Tourette syndrome with plans for evaluation in other compulsion-related disorders, including Prader-Willi Syndrome. Cash balance of $44.8 million as of December 31 2024. Management hosting conference call and webcast today at 4:30 PM ET. “An important dimension of our strategic options exploration has been the development of a portfolio of programs with near-term value drivers that can address under-served markets. While we maintain deep expertise in diseases of the central nervous system, as we evaluate strategic opportunities, the broad drug development expertise of our Team provides flexibility to be opportunistic,” commented Maged Shenouda, CFO of Relmada. “With a $44.8 million cash balance, as of December 31, 2024, and clean balance sheet, we begin the year with solid financial strength.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/relmada-therapeutics-reports-fourth-quarter-200500181.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4081","BK4532","PWS","PAM","BK4179","RLMD","ALLO","CDC","IE00B1B80R65.USD","TS","BK4139","LENZ","BK4563","BK4505","BK4007"],"gpt_icon":0},{"id":"2519315319","title":"Allogene Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2519315319","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519315319?lang=en_us&edition=fundamental","pubTime":"2025-03-15 20:18","pubTimestamp":1742041124,"startTime":"0","endTime":"0","summary":"NasdaqGS:ALLO Earnings and Revenue History March 15th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 36%. Earnings per share  exceeded analyst estimates by 3.0%.Looking ahead, revenue is forecast to grow 60% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Biotechs industry in the US.The company's shares are down 11% from a week ago.We should say that we've discovered 5 warning signs for Allogene Therapeutics (2 shouldn't be ignored!) that you should be aware of before investing here.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/allogene-therapeutics-full-2024-earnings-121844429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALLO","LENZ"],"gpt_icon":0},{"id":"2519381281","title":"Allogene Therapeutics Price Target Maintained With a $10.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2519381281","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519381281?lang=en_us&edition=fundamental","pubTime":"2025-03-14 23:46","pubTimestamp":1741967160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALLO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 14, 2025 11:46 ET (15:46 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ALLO"],"gpt_icon":0},{"id":"2519015098","title":"Allogene's Q4 Loss Narrower Than Expected, Revenues Nil","url":"https://stock-news.laohu8.com/highlight/detail?id=2519015098","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519015098?lang=en_us&edition=fundamental","pubTime":"2025-03-14 19:52","pubTimestamp":1741953120,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics ALLO incurred a loss of 28 cents per share in fourth-quarter 2024, narrower than the Zacks Consensus Estimate of a loss of 34 cents. In the year-ago period, the company had incurred a loss of 51 cents per share.See the Zacks Earnings Calendar to stay ahead of market-making news.ALLO did not generate revenues during the reported quarter. The Zacks Consensus Estimate for fourth-quarter sales was pegged at $0.07 million. In the year-ago period, the company recorded revenues of $0.02 million.Year to date, shares of Allogene have lost 11% against the industry’s 6% growth.Research & development (R&D) expenses totaled $45 million, down 18% from the year-ago quarter’s level.General and administrative (G&A) expenses declined 10% year over year to $15.5 million.As of Dec. 31, 2024, Allogene had $373.1 million of cash, cash equivalents and investments, compared with $403.4 million as of Sept. 30, 2024. The company claims that its cash runway will fund operations into the sec","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/allogenes-q4-loss-narrower-expected-115200427.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALLO","CTMX"],"gpt_icon":0},{"id":"2519587785","title":"RBC Capital Sticks to Their Buy Rating for Allogene Therapeutics (ALLO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2519587785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519587785?lang=en_us&edition=fundamental","pubTime":"2025-03-14 19:06","pubTimestamp":1741950385,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Luca Issi from RBC Capital maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report), with a price ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-allogene-therapeutics-allo-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-allogene-therapeutics-allo-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALLO"],"gpt_icon":0},{"id":"2519066894","title":"TD Cowen Keeps Their Buy Rating on Allogene Therapeutics (ALLO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2519066894","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519066894?lang=en_us&edition=fundamental","pubTime":"2025-03-14 08:25","pubTimestamp":1741911911,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report) yesterday. The company’s shares closed y...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-keeps-their-buy-rating-on-allogene-therapeutics-allo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-keeps-their-buy-rating-on-allogene-therapeutics-allo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COWN","ALLO","TD"],"gpt_icon":0},{"id":"2519860381","title":"Allogene Therapeutics Inc Q4 Loss Per Share $0.28","url":"https://stock-news.laohu8.com/highlight/detail?id=2519860381","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519860381?lang=en_us&edition=fundamental","pubTime":"2025-03-14 05:45","pubTimestamp":1741902358,"startTime":"0","endTime":"0","summary":"March 13 (Reuters) - Allogene Therapeutics Inc ::*ALLOGENE THERAPEUTICS INC - Q4 LOSS PER SHARE $0.28  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 13-MAR-202520:02:00.31 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nRSDqY1gN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","ALLO"],"gpt_icon":0},{"id":"2519864094","title":"Allogene Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2519864094","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519864094?lang=en_us&edition=fundamental","pubTime":"2025-03-14 05:01","pubTimestamp":1741899719,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryAllogene Therapeutics Inc ALLO.OQ reported a quarterly adjusted loss of 28 cents per share for the quarter","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nL8N3PW23G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLO"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":96,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALLO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-13","symbol":"ALLO","fiscalQuarterEnding":"2024/12","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2024-11-07","symbol":"ALLO","fiscalQuarterEnding":"2024/09","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2024-08-07","symbol":"ALLO","fiscalQuarterEnding":"2024/06","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-0.32},{"market":"US","date":"2024-05-13","symbol":"ALLO","fiscalQuarterEnding":"2024/03","expectedEps":-0.38,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2024-03-14","symbol":"ALLO","fiscalQuarterEnding":"2023/12","expectedEps":-0.47,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710388800000,"reportTimeType":"post","actualEps":-0.43}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALLO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALLO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5333,"hold":0.1333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5333,"analysts":15,"updateTime":1742011200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALLO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALLO","date":"2025-04-25","current":-1.324219,"percent":0.962662,"low":-32.642437,"twenty":-16.38365,"median":-4.454665,"eighty":-1.8199,"high":-1.035677,"avg":-8.255932,"sd":8.076201,"marketCap":341105638},"quantilePoints":[{"date":"2020-05-01","current":-19.313172,"twenty":-128717.983625,"median":-20.985914,"eighty":-14.920302,"marketCap":3565095674},{"date":"2020-05-08","current":-18.972964,"twenty":-128670.395667,"median":-20.938532,"eighty":-14.923683,"marketCap":3936662257},{"date":"2020-05-15","current":-27.127532,"twenty":-128214.835667,"median":-20.927873,"eighty":-14.959059,"marketCap":5628637440},{"date":"2020-05-22","current":-32.642437,"twenty":-127115.307333,"median":-20.988186,"eighty":-15.034865,"marketCap":6772913989},{"date":"2020-05-29","current":-29.090669,"twenty":-125818.1121,"median":-21.018149,"eighty":-15.038908,"marketCap":6035964799},{"date":"2020-06-05","current":-28.154608,"twenty":-125362.460425,"median":-21.101225,"eighty":-15.042238,"marketCap":5841743348},{"date":"2020-06-12","current":-26.741264,"twenty":-125167.645342,"median":-21.34254,"eighty":-15.052628,"marketCap":5548491395},{"date":"2020-06-19","current":-26.351604,"twenty":-123317.452191,"median":-21.370232,"eighty":-15.067209,"marketCap":5467641557},{"date":"2020-06-26","current":-28.372554,"twenty":-122766.755092,"median":-21.425301,"eighty":-15.085062,"marketCap":5886964444},{"date":"2020-07-02","current":-29.693436,"twenty":-122411.666725,"median":-21.484956,"eighty":-15.099106,"marketCap":6161031690},{"date":"2020-07-10","current":-28.628112,"twenty":-122130.57855,"median":-21.512647,"eighty":-15.112891,"marketCap":5939989714},{"date":"2020-07-17","current":-28.41417,"twenty":-120852.809358,"median":-21.632371,"eighty":-15.149784,"marketCap":5895599320},{"date":"2020-07-24","current":-25.786695,"twenty":-118796.77005,"median":-21.690696,"eighty":-15.211389,"marketCap":5350429782},{"date":"2020-07-31","current":-24.516415,"twenty":-117386.342967,"median":-21.749941,"eighty":-15.262228,"marketCap":5086861813},{"date":"2020-08-07","current":-23.068229,"twenty":-116963.771775,"median":-21.815069,"eighty":-15.302048,"marketCap":5241539822},{"date":"2020-08-14","current":-22.639109,"twenty":-115764.848892,"median":-21.850929,"eighty":-15.323938,"marketCap":5144035759},{"date":"2020-08-21","current":-22.326465,"twenty":-113858.364958,"median":-21.88451,"eighty":-15.339533,"marketCap":5072997085},{"date":"2020-08-28","current":-21.449836,"twenty":-113052.531558,"median":-21.850929,"eighty":-15.350911,"marketCap":4873810214},{"date":"2020-09-04","current":-20.248302,"twenty":-113013.222625,"median":-21.815069,"eighty":-15.356579,"marketCap":4600798839},{"date":"2020-09-11","current":-19.849834,"twenty":-112698.751042,"median":-21.773611,"eighty":-15.368663,"marketCap":4510259352},{"date":"2020-09-18","current":-23.295049,"twenty":-111676.7184,"median":-21.798486,"eighty":-15.39431,"marketCap":5293077684},{"date":"2020-09-25","current":-22.694282,"twenty":-110733.303667,"median":-21.781903,"eighty":-15.424201,"marketCap":5156571996},{"date":"2020-10-02","current":-22.42455,"twenty":-66346.905025,"median":-21.833475,"eighty":-15.446635,"marketCap":5095283728},{"date":"2020-10-09","current":-25.465166,"twenty":-32.123278,"median":-21.864819,"eighty":-15.456704,"marketCap":5786169657},{"date":"2020-10-16","current":-24.049073,"twenty":-31.053945,"median":-21.899539,"eighty":-15.474746,"marketCap":5464406251},{"date":"2020-10-23","current":-22.252902,"twenty":-30.499998,"median":-21.914568,"eighty":-15.494275,"marketCap":5056282103},{"date":"2020-10-30","current":-20.793896,"twenty":-30.117541,"median":-21.899539,"eighty":-15.519547,"marketCap":4724768290},{"date":"2020-11-06","current":-16.069607,"twenty":-29.763062,"median":-21.864819,"eighty":-15.5887,"marketCap":3899788225},{"date":"2020-11-13","current":-18.537852,"twenty":-29.652871,"median":-21.833475,"eighty":-15.667503,"marketCap":4498784474},{"date":"2020-11-20","current":-18.052296,"twenty":-29.579943,"median":-21.805392,"eighty":-15.676049,"marketCap":4380949146},{"date":"2020-11-27","current":-18.219928,"twenty":-29.522101,"median":-21.773611,"eighty":-15.706189,"marketCap":4421630391},{"date":"2020-12-04","current":-19.451161,"twenty":-29.361862,"median":-21.722315,"eighty":-15.79419,"marketCap":4720427114},{"date":"2020-12-11","current":-15.84995,"twenty":-29.3261,"median":-21.682404,"eighty":-15.838198,"marketCap":3846481767},{"date":"2020-12-18","current":-15.688098,"twenty":-29.203647,"median":-21.66746,"eighty":-15.734976,"marketCap":3807203325},{"date":"2020-12-24","current":-15.797926,"twenty":-29.199397,"median":-21.632371,"eighty":-15.783758,"marketCap":3833856554},{"date":"2020-12-31","current":-14.589816,"twenty":-29.129678,"median":-21.578578,"eighty":-15.683214,"marketCap":3540671036},{"date":"2021-01-08","current":-16.11007,"twenty":-29.094985,"median":-21.512647,"eighty":-15.665105,"marketCap":3909607836},{"date":"2021-01-15","current":-18.722826,"twenty":-29.085837,"median":-21.484956,"eighty":-15.668424,"marketCap":4543674123},{"date":"2021-01-22","current":-17.780615,"twenty":-29.081387,"median":-21.441682,"eighty":-15.679632,"marketCap":4315017475},{"date":"2021-01-29","current":-20.058106,"twenty":-29.079226,"median":-21.417075,"eighty":-15.687578,"marketCap":4867721274},{"date":"2021-02-05","current":-20.358689,"twenty":-29.059413,"median":-21.366276,"eighty":-15.695035,"marketCap":4940666953},{"date":"2021-02-12","current":-20.075448,"twenty":-28.895623,"median":-21.330672,"eighty":-15.713532,"marketCap":4871929678},{"date":"2021-02-19","current":-20.069667,"twenty":-28.779198,"median":-21.3211,"eighty":-15.747172,"marketCap":4870526877},{"date":"2021-02-26","current":-19.510296,"twenty":-28.705134,"median":-21.268993,"eighty":-15.789425,"marketCap":4881885762},{"date":"2021-03-05","current":-19.111209,"twenty":-28.62932,"median":-21.180345,"eighty":-15.813122,"marketCap":4782025812},{"date":"2021-03-12","current":-21.629392,"twenty":-28.549665,"median":-21.223136,"eighty":-15.840479,"marketCap":5412128036},{"date":"2021-03-19","current":-20.803113,"twenty":-28.424864,"median":-21.180345,"eighty":-15.848374,"marketCap":5205375744},{"date":"2021-03-26","current":-18.987548,"twenty":-28.40809,"median":-21.126559,"eighty":-15.84995,"marketCap":4751083292},{"date":"2021-04-01","current":-19.633957,"twenty":-28.393688,"median":-21.081445,"eighty":-15.853418,"marketCap":4912828282},{"date":"2021-04-09","current":-18.447938,"twenty":-28.354062,"median":-21.006281,"eighty":-15.878853,"marketCap":4616061386},{"date":"2021-04-16","current":-18.273688,"twenty":-28.264241,"median":-20.976017,"eighty":-15.933588,"marketCap":4572460563},{"date":"2021-04-23","current":-19.462576,"twenty":-28.191593,"median":-20.927873,"eighty":-15.982492,"marketCap":4869945125},{"date":"2021-04-30","current":-17.483522,"twenty":-28.153287,"median":-20.900528,"eighty":-16.044634,"marketCap":4374744429},{"date":"2021-05-07","current":-18.574304,"twenty":-28.140827,"median":-20.824306,"eighty":-16.056451,"marketCap":4248983398},{"date":"2021-05-14","current":-17.015102,"twenty":-28.110712,"median":-20.785365,"eighty":-16.066082,"marketCap":3892306577},{"date":"2021-05-21","current":-16.09938,"twenty":-28.045215,"median":-20.757114,"eighty":-16.075562,"marketCap":3682829714},{"date":"2021-05-28","current":-15.901386,"twenty":-27.798929,"median":-20.702003,"eighty":-15.982492,"marketCap":3637537419},{"date":"2021-06-04","current":-14.731984,"twenty":-27.771552,"median":-20.677935,"eighty":-15.867292,"marketCap":3370029804},{"date":"2021-06-11","current":-16.148878,"twenty":-27.752287,"median":-20.584126,"eighty":-15.84995,"marketCap":3694152788},{"date":"2021-06-18","current":-15.146534,"twenty":-27.745135,"median":-20.567167,"eighty":-15.783758,"marketCap":3464860546},{"date":"2021-06-25","current":-14.960915,"twenty":-27.705487,"median":-20.54455,"eighty":-15.697205,"marketCap":3422399019},{"date":"2021-07-02","current":-16.26025,"twenty":-27.672486,"median":-20.524004,"eighty":-15.697205,"marketCap":3719629703},{"date":"2021-07-09","current":-14.911416,"twenty":-27.651352,"median":-20.43363,"eighty":-15.668424,"marketCap":3411075946},{"date":"2021-07-16","current":-14.001882,"twenty":-27.614367,"median":-20.349588,"eighty":-15.61339,"marketCap":3203014467},{"date":"2021-07-23","current":-13.643018,"twenty":-27.477084,"median":-20.242529,"eighty":-15.573595,"marketCap":3120922183},{"date":"2021-07-30","current":-13.581145,"twenty":-27.372009,"median":-20.19926,"eighty":-15.486486,"marketCap":3106768340},{"date":"2021-08-06","current":-13.937332,"twenty":-27.187994,"median":-20.183031,"eighty":-15.440342,"marketCap":3327091981},{"date":"2021-08-13","current":-12.769931,"twenty":-27.13327,"median":-20.135965,"eighty":-15.396829,"marketCap":3048412481},{"date":"2021-08-20","current":-13.967112,"twenty":-27.128016,"median":-20.084647,"eighty":-15.357651,"marketCap":3334201152},{"date":"2021-08-27","current":-14.532944,"twenty":-27.087978,"median":-20.058106,"eighty":-15.319398,"marketCap":3469275399},{"date":"2021-09-03","current":-15.17025,"twenty":-27.066547,"median":-19.991439,"eighty":-15.277942,"marketCap":3621411656},{"date":"2021-09-10","current":-14.735453,"twenty":-26.951342,"median":-19.940072,"eighty":-15.211389,"marketCap":3517617761},{"date":"2021-09-17","current":-15.116645,"twenty":-26.795343,"median":-19.884693,"eighty":-15.124129,"marketCap":3608615148},{"date":"2021-09-24","current":-15.283416,"twenty":-26.678135,"median":-19.849922,"eighty":-15.11715,"marketCap":3648426505},{"date":"2021-10-01","current":-14.604418,"twenty":-26.569222,"median":-19.821108,"eighty":-15.112387,"marketCap":3486337409},{"date":"2021-10-08","current":-7.820392,"twenty":-26.52467,"median":-19.746249,"eighty":-15.06736,"marketCap":1866868278},{"date":"2021-10-15","current":-9.815694,"twenty":-26.488509,"median":-19.739643,"eighty":-15.039637,"marketCap":2343182728},{"date":"2021-10-22","current":-9.422589,"twenty":-26.410782,"median":-19.66854,"eighty":-14.968339,"marketCap":2249341672},{"date":"2021-10-29","current":-10.268359,"twenty":-26.360977,"median":-19.633957,"eighty":-14.938394,"marketCap":2451242126},{"date":"2021-11-05","current":-11.448707,"twenty":-26.35097,"median":-19.577031,"eighty":-14.909523,"marketCap":2870270991},{"date":"2021-11-12","current":-10.948466,"twenty":-26.268966,"median":-19.520526,"eighty":-14.896677,"marketCap":2744856965},{"date":"2021-11-19","current":-10.69266,"twenty":-25.997664,"median":-19.458331,"eighty":-14.830197,"marketCap":2680724793},{"date":"2021-11-26","current":-10.220842,"twenty":-25.82651,"median":-19.416087,"eighty":-14.809383,"marketCap":2562436565},{"date":"2021-12-03","current":-10.016198,"twenty":-25.773439,"median":-19.283528,"eighty":-14.742014,"marketCap":2511130827},{"date":"2021-12-10","current":-10.249265,"twenty":-25.711764,"median":-19.163016,"eighty":-14.695169,"marketCap":2569562362},{"date":"2021-12-17","current":-8.987292,"twenty":-25.583781,"median":-19.115579,"eighty":-14.620796,"marketCap":2253176979},{"date":"2021-12-23","current":-8.902023,"twenty":-25.481704,"median":-19.099967,"eighty":-14.591026,"marketCap":2231799589},{"date":"2021-12-31","current":-8.481366,"twenty":-25.460584,"median":-19.052311,"eighty":-14.49675,"marketCap":2126337794},{"date":"2022-01-07","current":-7.65142,"twenty":-25.434926,"median":-18.972964,"eighty":-14.45075,"marketCap":1918264525},{"date":"2022-01-14","current":-7.549098,"twenty":-25.370845,"median":-18.912042,"eighty":-14.374511,"marketCap":1892611656},{"date":"2022-01-21","current":-6.457662,"twenty":-25.231783,"median":-18.839368,"eighty":-14.322288,"marketCap":1618981055},{"date":"2022-01-28","current":-6.037004,"twenty":-25.124812,"median":-18.790783,"eighty":-14.276831,"marketCap":1513519261},{"date":"2022-02-04","current":-6.264387,"twenty":-25.073649,"median":-18.741054,"eighty":-14.246482,"marketCap":1570525636},{"date":"2022-02-11","current":-5.76983,"twenty":-24.932692,"median":-18.689285,"eighty":-14.211106,"marketCap":1446536770},{"date":"2022-02-18","current":-5.286642,"twenty":-24.919572,"median":-18.675482,"eighty":-14.155515,"marketCap":1325398223},{"date":"2022-02-25","current":-5.237841,"twenty":-24.910169,"median":-18.641491,"eighty":-14.089501,"marketCap":1346151378},{"date":"2022-03-04","current":-4.465773,"twenty":-24.856433,"median":-18.614852,"eighty":-13.975129,"marketCap":1147726096},{"date":"2022-03-11","current":-4.537981,"twenty":-24.80629,"median":-18.575761,"eighty":-13.919313,"marketCap":1166283856},{"date":"2022-03-18","current":-5.421138,"twenty":-24.791816,"median":-18.537852,"eighty":-13.824271,"marketCap":1393259539},{"date":"2022-03-25","current":-5.360039,"twenty":-24.745062,"median":-18.517177,"eighty":-13.759752,"marketCap":1377556819},{"date":"2022-04-01","current":-5.24895,"twenty":-24.663369,"median":-18.481663,"eighty":-13.698958,"marketCap":1349006418},{"date":"2022-04-08","current":-4.910129,"twenty":-24.556916,"median":-18.469454,"eighty":-13.641781,"marketCap":1261927697},{"date":"2022-04-14","current":-4.608672,"twenty":-24.523728,"median":-18.439507,"eighty":-13.603773,"marketCap":1184451691},{"date":"2022-04-22","current":-4.35729,"twenty":-24.477635,"median":-18.313035,"eighty":-13.564932,"marketCap":1119845235},{"date":"2022-04-29","current":-4.665479,"twenty":-24.441832,"median":-18.271722,"eighty":-13.51369,"marketCap":1199051399},{"date":"2022-05-06","current":-4.338635,"twenty":-24.350625,"median":-18.24883,"eighty":-13.47653,"marketCap":1318250882},{"date":"2022-05-13","current":-3.41703,"twenty":-24.272198,"median":-18.214147,"eighty":-13.43938,"marketCap":1038230270},{"date":"2022-05-20","current":-3.535184,"twenty":-24.194972,"median":-18.163547,"eighty":-13.367297,"marketCap":1074130348},{"date":"2022-05-27","current":-3.780946,"twenty":-24.101793,"median":-18.077113,"eighty":-13.243821,"marketCap":1148802512},{"date":"2022-06-03","current":-3.932183,"twenty":-24.060108,"median":-18.06159,"eighty":-13.190251,"marketCap":1194754612},{"date":"2022-06-10","current":-4.603301,"twenty":-24.027743,"median":-17.98293,"eighty":-13.117204,"marketCap":1398667058},{"date":"2022-06-17","current":-5.179895,"twenty":-23.989114,"median":-17.951138,"eighty":-12.938707,"marketCap":1573859441},{"date":"2022-06-24","current":-5.803751,"twenty":-23.979164,"median":-17.921762,"eighty":-12.772357,"marketCap":1763411855},{"date":"2022-07-01","current":-5.439835,"twenty":-23.96372,"median":-17.857317,"eighty":-12.530495,"marketCap":1652839614},{"date":"2022-07-08","current":-5.685597,"twenty":-23.901946,"median":-17.780615,"eighty":-12.328703,"marketCap":1727511777},{"date":"2022-07-15","current":-6.054239,"twenty":-23.879665,"median":-17.691917,"eighty":-11.170164,"marketCap":1839520022},{"date":"2022-07-22","current":-6.314179,"twenty":-23.828383,"median":-17.626932,"eighty":-10.948466,"marketCap":1918500195},{"date":"2022-07-29","current":-6.134584,"twenty":-23.705543,"median":-17.59185,"eighty":-10.800667,"marketCap":1863932075},{"date":"2022-08-05","current":-7.306677,"twenty":-23.697251,"median":-17.538967,"eighty":-10.69266,"marketCap":2220060854},{"date":"2022-08-12","current":-8.062204,"twenty":-23.570911,"median":-17.452841,"eighty":-10.510754,"marketCap":2480667731},{"date":"2022-08-19","current":-6.921811,"twenty":-23.514837,"median":-17.370093,"eighty":-10.266318,"marketCap":2129779078},{"date":"2022-08-26","current":-6.59465,"twenty":-23.443168,"median":-17.343792,"eighty":-10.220842,"marketCap":2029114300},{"date":"2022-09-02","current":-6.636713,"twenty":-23.37196,"median":-17.295567,"eighty":-9.815694,"marketCap":2042056915},{"date":"2022-09-09","current":-7.043329,"twenty":-23.333983,"median":-17.225694,"eighty":-9.494063,"marketCap":2167168852},{"date":"2022-09-16","current":-6.389005,"twenty":-23.304303,"median":-17.168273,"eighty":-9.413059,"marketCap":1965839297},{"date":"2022-09-23","current":-4.963514,"twenty":-23.295891,"median":-17.123016,"eighty":-8.970238,"marketCap":1527228481},{"date":"2022-09-30","current":-5.047641,"twenty":-23.22545,"median":-17.01924,"eighty":-8.791743,"marketCap":1553113710},{"date":"2022-10-07","current":-4.841996,"twenty":-23.18815,"median":-16.933399,"eighty":-8.734897,"marketCap":1489838707},{"date":"2022-10-14","current":-4.757869,"twenty":-23.163275,"median":-16.832624,"eighty":-8.377907,"marketCap":1463953478},{"date":"2022-10-21","current":-4.701784,"twenty":-23.131767,"median":-16.626752,"eighty":-8.053946,"marketCap":1446696659},{"date":"2022-10-28","current":-5.03362,"twenty":-23.123748,"median":-16.609019,"eighty":-7.819568,"marketCap":1548799505},{"date":"2022-11-04","current":-4.308044,"twenty":-23.118497,"median":-16.462729,"eighty":-7.719634,"marketCap":1346922838},{"date":"2022-11-11","current":-4.621692,"twenty":-23.078037,"median":-16.372736,"eighty":-7.512226,"marketCap":1444985743},{"date":"2022-11-18","current":-4.723166,"twenty":-23.040787,"median":-16.295044,"eighty":-7.268603,"marketCap":1476711976},{"date":"2022-11-25","current":-4.967627,"twenty":-23.028761,"median":-16.231769,"eighty":-7.107827,"marketCap":1553143358},{"date":"2022-12-02","current":-4.363393,"twenty":-22.975759,"median":-16.162506,"eighty":-6.958297,"marketCap":1364228056},{"date":"2022-12-09","current":-4.040521,"twenty":-22.92282,"median":-16.136504,"eighty":-6.795851,"marketCap":1263280949},{"date":"2022-12-16","current":-3.187214,"twenty":-22.884679,"median":-16.118741,"eighty":-6.737666,"marketCap":996492164},{"date":"2022-12-23","current":-2.74903,"twenty":-22.855762,"median":-16.09938,"eighty":-6.648267,"marketCap":859492517},{"date":"2022-12-30","current":-2.901242,"twenty":-22.845812,"median":-16.065201,"eighty":-6.624678,"marketCap":907081868},{"date":"2023-01-06","current":-2.808992,"twenty":-22.842858,"median":-16.042226,"eighty":-6.551135,"marketCap":878239837},{"date":"2023-01-13","current":-3.256401,"twenty":-22.839916,"median":-15.931803,"eighty":-6.459821,"marketCap":1018123687},{"date":"2023-01-20","current":-3.021166,"twenty":-22.833946,"median":-15.884339,"eighty":-6.44509,"marketCap":944576508},{"date":"2023-01-27","current":-3.653074,"twenty":-22.804627,"median":-15.84995,"eighty":-6.403977,"marketCap":1142144419},{"date":"2023-02-03","current":-3.588499,"twenty":-22.792366,"median":-15.822247,"eighty":-6.365636,"marketCap":1121954998},{"date":"2023-02-10","current":-3.168765,"twenty":-22.752014,"median":-15.783758,"eighty":-6.281441,"marketCap":990723757},{"date":"2023-02-17","current":-3.320976,"twenty":-22.724933,"median":-15.698432,"eighty":-6.150644,"marketCap":1038313108},{"date":"2023-02-24","current":-2.855117,"twenty":-22.720065,"median":-15.692652,"eighty":-6.050792,"marketCap":892660853},{"date":"2023-03-03","current":-2.602093,"twenty":-22.718848,"median":-15.668884,"eighty":-5.957523,"marketCap":865539324},{"date":"2023-03-10","current":-2.476115,"twenty":-22.699195,"median":-15.650358,"eighty":-5.791024,"marketCap":823635083},{"date":"2023-03-17","current":-2.38489,"twenty":-22.694036,"median":-15.59202,"eighty":-5.754599,"marketCap":793290632},{"date":"2023-03-24","current":-2.180719,"twenty":-22.650082,"median":-15.578958,"eighty":-5.643062,"marketCap":725376862},{"date":"2023-03-31","current":-2.145966,"twenty":-22.606719,"median":-15.536778,"eighty":-5.533933,"marketCap":713817072},{"date":"2023-04-06","current":-2.145966,"twenty":-22.596133,"median":-15.486836,"eighty":-5.526161,"marketCap":713817072},{"date":"2023-04-14","current":-2.193751,"twenty":-22.59183,"median":-15.476469,"eighty":-5.47859,"marketCap":729711784},{"date":"2023-04-21","current":-2.167687,"twenty":-22.582762,"median":-15.444878,"eighty":-5.423849,"marketCap":721041941},{"date":"2023-04-28","current":-2.331585,"twenty":-22.567942,"median":-15.411502,"eighty":-5.378822,"marketCap":775559814},{"date":"2023-05-05","current":-2.67629,"twenty":-22.556495,"median":-15.387839,"eighty":-5.296718,"marketCap":940678449},{"date":"2023-05-12","current":-2.564259,"twenty":-22.5382,"median":-15.360906,"eighty":-5.264421,"marketCap":901301211},{"date":"2023-05-19","current":-2.522766,"twenty":-22.523168,"median":-15.347235,"eighty":-5.220067,"marketCap":886717049},{"date":"2023-05-26","current":-2.26966,"twenty":-22.494685,"median":-15.329523,"eighty":-5.146724,"marketCap":797753661},{"date":"2023-06-02","current":-2.207421,"twenty":-22.461519,"median":-15.318827,"eighty":-5.12616,"marketCap":775877418},{"date":"2023-06-09","current":-2.406586,"twenty":-22.436936,"median":-15.307241,"eighty":-5.087067,"marketCap":845881396},{"date":"2023-06-16","current":-2.062196,"twenty":-22.431982,"median":-15.280863,"eighty":-5.062594,"marketCap":724832851},{"date":"2023-06-23","current":-1.950165,"twenty":-22.42371,"median":-15.264093,"eighty":-5.040163,"marketCap":685455614},{"date":"2023-06-30","current":-1.900373,"twenty":-22.420352,"median":-15.20471,"eighty":-4.999,"marketCap":667954619},{"date":"2023-07-07","current":-2.082942,"twenty":-22.399189,"median":-15.158392,"eighty":-4.959528,"marketCap":732124932},{"date":"2023-07-14","current":-2.163853,"twenty":-22.385151,"median":-15.117486,"eighty":-4.907907,"marketCap":760564048},{"date":"2023-07-21","current":-2.190823,"twenty":-22.379709,"median":-15.097383,"eighty":-4.870137,"marketCap":770043753},{"date":"2023-07-28","current":-1.962613,"twenty":-22.365629,"median":-15.070241,"eighty":-4.834519,"marketCap":689830862},{"date":"2023-08-04","current":-2.429176,"twenty":-22.333634,"median":-15.048949,"eighty":-4.780355,"marketCap":861599516},{"date":"2023-08-11","current":-1.989656,"twenty":-22.302039,"median":-15.039215,"eighty":-4.750531,"marketCap":705706996},{"date":"2023-08-18","current":-1.890409,"twenty":-22.281125,"median":-14.976471,"eighty":-4.726099,"marketCap":670505460},{"date":"2023-08-25","current":-1.800615,"twenty":-22.26271,"median":-14.959059,"eighty":-4.690269,"marketCap":638656450},{"date":"2023-09-01","current":-1.838423,"twenty":-22.254128,"median":-14.935942,"eighty":-4.655464,"marketCap":652066559},{"date":"2023-09-08","current":-1.890409,"twenty":-22.226501,"median":-14.915859,"eighty":-4.613716,"marketCap":670505460},{"date":"2023-09-15","current":-1.866779,"twenty":-22.199407,"median":-14.907739,"eighty":-4.562564,"marketCap":662124141},{"date":"2023-09-22","current":-1.758081,"twenty":-22.155099,"median":-14.902096,"eighty":-4.535759,"marketCap":623570077},{"date":"2023-09-29","current":-1.611574,"twenty":-22.125027,"median":-14.890312,"eighty":-4.47888,"marketCap":571605904},{"date":"2023-10-06","current":-1.488697,"twenty":-22.083887,"median":-14.828304,"eighty":-4.453624,"marketCap":528023049},{"date":"2023-10-13","current":-1.398903,"twenty":-22.021504,"median":-14.806926,"eighty":-4.392913,"marketCap":496174040},{"date":"2023-10-20","current":-1.408355,"twenty":-21.920407,"median":-14.732656,"eighty":-4.341249,"marketCap":499526567},{"date":"2023-10-27","current":-1.24767,"twenty":-21.858588,"median":-14.678091,"eighty":-4.324649,"marketCap":442533603},{"date":"2023-11-03","current":-1.500595,"twenty":-21.791299,"median":-14.597163,"eighty":-4.250351,"marketCap":499480406},{"date":"2023-11-10","current":-1.271472,"twenty":-21.701761,"median":-14.505855,"eighty":-4.13646,"marketCap":423215804},{"date":"2023-11-17","current":-1.420611,"twenty":-21.666847,"median":-14.444042,"eighty":-3.884921,"marketCap":472857420},{"date":"2023-11-24","current":-1.435778,"twenty":-21.606973,"median":-14.367423,"eighty":-3.736519,"marketCap":477905720},{"date":"2023-12-01","current":-1.188055,"twenty":-21.531996,"median":-14.285577,"eighty":-3.670601,"marketCap":395450155},{"date":"2023-12-08","current":-1.274,"twenty":-21.460314,"median":-14.255927,"eighty":-3.607628,"marketCap":424057188},{"date":"2023-12-15","current":-1.370055,"twenty":-21.374979,"median":-14.211106,"eighty":-3.560824,"marketCap":456029754},{"date":"2023-12-22","current":-1.395333,"twenty":-21.322326,"median":-14.13984,"eighty":-3.533294,"marketCap":464443587},{"date":"2023-12-29","current":-1.653166,"twenty":-21.268379,"median":-14.008069,"eighty":-3.467127,"marketCap":550264684},{"date":"2024-01-05","current":-1.713833,"twenty":-21.128686,"median":-13.967112,"eighty":-3.374494,"marketCap":570457884},{"date":"2024-01-12","current":-1.622833,"twenty":-20.999951,"median":-13.847237,"eighty":-3.288105,"marketCap":540168085},{"date":"2024-01-19","current":-1.617777,"twenty":-20.926148,"median":-13.775851,"eighty":-3.237951,"marketCap":538485318},{"date":"2024-01-26","current":-1.617777,"twenty":-20.843295,"median":-13.725947,"eighty":-3.189059,"marketCap":538485318},{"date":"2024-02-02","current":-1.875611,"twenty":-20.757114,"median":-13.643018,"eighty":-3.045151,"marketCap":624306416},{"date":"2024-02-09","current":-2.209277,"twenty":-20.678726,"median":-13.581145,"eighty":-2.954746,"marketCap":735369012},{"date":"2024-02-16","current":-2.507555,"twenty":-20.569541,"median":-13.523798,"eighty":-2.866187,"marketCap":834652243},{"date":"2024-02-23","current":-2.204222,"twenty":-20.53631,"median":-13.479021,"eighty":-2.792973,"marketCap":733686246},{"date":"2024-03-01","current":-2.482277,"twenty":-20.368481,"median":-13.450518,"eighty":-2.74483,"marketCap":826238410},{"date":"2024-03-08","current":-2.815944,"twenty":-20.232312,"median":-13.366427,"eighty":-2.733115,"marketCap":937301007},{"date":"2024-03-15","current":-2.316309,"twenty":-20.232312,"median":-13.215177,"eighty":-2.663292,"marketCap":758046859},{"date":"2024-03-22","current":-2.263068,"twenty":-20.232312,"median":-13.137784,"eighty":-2.619459,"marketCap":740622924},{"date":"2024-03-28","current":-2.304402,"twenty":-20.232312,"median":-12.979561,"eighty":-2.590948,"marketCap":754150284},{"date":"2024-04-05","current":-2.092563,"twenty":-20.235598,"median":-12.656765,"eighty":-2.565844,"marketCap":684822567},{"date":"2024-04-12","current":-2.061562,"twenty":-20.235598,"median":-12.436968,"eighty":-2.524426,"marketCap":674677048},{"date":"2024-04-19","current":-1.78772,"twenty":-20.235598,"median":-11.170164,"eighty":-2.507555,"marketCap":585058292},{"date":"2024-04-26","current":-1.489357,"twenty":-20.232312,"median":-10.939939,"eighty":-2.476779,"marketCap":487414450},{"date":"2024-05-03","current":-1.549349,"twenty":-20.232312,"median":-10.763718,"eighty":-2.449125,"marketCap":507047607},{"date":"2024-05-10","current":-1.491965,"twenty":-20.232312,"median":-10.570442,"eighty":-2.423446,"marketCap":488268066},{"date":"2024-05-17","current":-2.150009,"twenty":-20.232312,"median":-10.267339,"eighty":-2.404926,"marketCap":628441086},{"date":"2024-05-24","current":-1.814293,"twenty":-20.232312,"median":-10.217798,"eighty":-2.379795,"marketCap":530312411},{"date":"2024-05-31","current":-1.75715,"twenty":-20.232312,"median":-9.802255,"eighty":-2.357966,"marketCap":513609658},{"date":"2024-06-07","current":-1.721436,"twenty":-20.232312,"median":-9.458326,"eighty":-2.340512,"marketCap":503170437},{"date":"2024-06-14","current":-1.814293,"twenty":-20.235598,"median":-9.321335,"eighty":-2.329295,"marketCap":530312411},{"date":"2024-06-21","current":-1.742864,"twenty":-20.238885,"median":-8.808228,"eighty":-2.309886,"marketCap":509433970},{"date":"2024-06-28","current":-1.742864,"twenty":-20.242458,"median":-8.742856,"eighty":-2.294956,"marketCap":509433970},{"date":"2024-07-05","current":-1.48572,"twenty":-20.242458,"median":-8.481366,"eighty":-2.266168,"marketCap":434271581},{"date":"2024-07-12","current":-1.914293,"twenty":-20.242458,"median":-8.062204,"eighty":-2.243046,"marketCap":559542229},{"date":"2024-07-15","current":-1.971437,"twenty":-20.242458,"median":-8.020916,"eighty":-2.232295,"marketCap":576244982},{"date":"2024-08-02","current":-1.957151,"twenty":-20.349588,"median":-7.694054,"eighty":-2.214333,"marketCap":572069294},{"date":"2024-08-09","current":-1.766151,"twenty":-20.242888,"median":-7.361135,"eighty":-2.204222,"marketCap":493503177},{"date":"2024-08-16","current":-1.721249,"twenty":-20.191056,"median":-7.164846,"eighty":-2.190823,"marketCap":480956486},{"date":"2024-08-23","current":-1.938276,"twenty":-20.093845,"median":-6.95807,"eighty":-2.175232,"marketCap":541598826},{"date":"2024-08-30","current":-1.990662,"twenty":-20.017285,"median":-6.784225,"eighty":-2.163853,"marketCap":556236632},{"date":"2024-09-06","current":-1.878406,"twenty":-19.907815,"median":-6.720841,"eighty":-2.145966,"marketCap":524869905},{"date":"2024-09-13","current":-1.990662,"twenty":-19.841932,"median":-6.638141,"eighty":-2.137278,"marketCap":556236632},{"date":"2024-09-20","current":-2.177754,"twenty":-19.740366,"median":-6.52603,"eighty":-2.12858,"marketCap":608514511},{"date":"2024-09-27","current":-2.035564,"twenty":-19.655531,"median":-6.451977,"eighty":-2.11323,"marketCap":568783323},{"date":"2024-10-04","current":-1.953243,"twenty":-19.537191,"median":-6.405838,"eighty":-2.102896,"marketCap":545781056},{"date":"2024-10-11","current":-1.960727,"twenty":-19.451161,"median":-6.340592,"eighty":-2.095433,"marketCap":547872171},{"date":"2024-10-18","current":-2.013113,"twenty":-19.182572,"median":-6.263289,"eighty":-2.085149,"marketCap":562509978},{"date":"2024-10-25","current":-1.900857,"twenty":-19.099967,"median":-6.094411,"eighty":-2.082942,"marketCap":531143250},{"date":"2024-10-31","current":-1.975694,"twenty":-18.987548,"median":-5.997212,"eighty":-2.068419,"marketCap":552054402},{"date":"2024-11-08","current":-2.345511,"twenty":-18.8198,"median":-5.784847,"eighty":-2.066176,"marketCap":667065736},{"date":"2024-11-15","current":-1.819833,"twenty":-18.730117,"median":-5.685597,"eighty":-2.062069,"marketCap":515793343},{"date":"2024-11-22","current":-1.560913,"twenty":-18.672674,"median":-5.55799,"eighty":-2.057716,"marketCap":442408112},{"date":"2024-11-29","current":-1.834628,"twenty":-18.617559,"median":-5.526672,"eighty":-2.050374,"marketCap":519986785},{"date":"2024-12-06","current":-1.583106,"twenty":-18.544789,"median":-5.472919,"eighty":-2.035564,"marketCap":448698274},{"date":"2024-12-13","current":-1.494334,"twenty":-18.484968,"median":-5.388824,"eighty":-2.012971,"marketCap":423537623},{"date":"2024-12-20","current":-1.361176,"twenty":-18.434448,"median":-5.342087,"eighty":-2.004132,"marketCap":385796647},{"date":"2024-12-27","current":-1.6053,"twenty":-18.274255,"median":-5.271168,"eighty":-1.99543,"marketCap":454988437},{"date":"2025-01-03","current":-1.627493,"twenty":-18.232743,"median":-5.246062,"eighty":-1.989226,"marketCap":461278600},{"date":"2025-01-10","current":-1.738458,"twenty":-18.134947,"median":-5.165179,"eighty":-1.981988,"marketCap":492729413},{"date":"2025-01-17","current":-1.361176,"twenty":-18.049948,"median":-5.108399,"eighty":-1.973991,"marketCap":385796647},{"date":"2025-01-24","current":-1.390766,"twenty":-17.95056,"median":-5.083674,"eighty":-1.968071,"marketCap":394183531},{"date":"2025-01-31","current":-1.420357,"twenty":-17.937793,"median":-5.049325,"eighty":-1.960727,"marketCap":402570414},{"date":"2025-02-07","current":-1.183631,"twenty":-17.868445,"median":-4.992941,"eighty":-1.952685,"marketCap":335475345},{"date":"2025-02-14","current":-1.043075,"twenty":-17.655471,"median":-4.937742,"eighty":-1.935282,"marketCap":295637648},{"date":"2025-02-21","current":-1.66818,"twenty":-17.555207,"median":-4.886637,"eighty":-1.928217,"marketCap":472810565},{"date":"2025-02-28","current":-1.44255,"twenty":-17.34147,"median":-4.837622,"eighty":-1.918389,"marketCap":408860577},{"date":"2025-03-07","current":-1.494334,"twenty":-17.020068,"median":-4.776822,"eighty":-1.896028,"marketCap":423537623},{"date":"2025-03-14","current":-1.594124,"twenty":-16.872428,"median":-4.732391,"eighty":-1.881608,"marketCap":410630354},{"date":"2025-03-21","current":-1.374826,"twenty":-16.872428,"median":-4.701784,"eighty":-1.868669,"marketCap":354141522},{"date":"2025-03-28","current":-1.315785,"twenty":-16.872428,"median":-4.660179,"eighty":-1.851045,"marketCap":338932991},{"date":"2025-04-04","current":-1.163963,"twenty":-16.872428,"median":-4.603301,"eighty":-1.838423,"marketCap":299825338},{"date":"2025-04-11","current":-1.155529,"twenty":-16.870721,"median":-4.547239,"eighty":-1.835284,"marketCap":297652691},{"date":"2025-04-17","current":-1.180832,"twenty":-16.643496,"median":-4.506056,"eighty":-1.832263,"marketCap":304170633},{"date":"2025-04-25","current":-1.324219,"twenty":-16.38365,"median":-4.454665,"eighty":-1.8199,"marketCap":341105638}],"updateTime":1745668651900}}}